MARCIANO', ILARIA
 Distribuzione geografica
Continente #
EU - Europa 221
NA - Nord America 200
AS - Asia 52
Totale 473
Nazione #
US - Stati Uniti d'America 200
IE - Irlanda 63
SE - Svezia 47
PL - Polonia 46
CN - Cina 37
IT - Italia 31
RO - Romania 15
BE - Belgio 7
SG - Singapore 7
NL - Olanda 4
VN - Vietnam 4
FR - Francia 3
IN - India 3
UA - Ucraina 3
DE - Germania 2
TH - Thailandia 1
Totale 473
Città #
Dublin 63
Chandler 57
Warsaw 46
Nyköping 25
Ashburn 19
Focsani 15
Beijing 11
Ann Arbor 10
Princeton 9
New York 8
Brussels 7
Messina 7
Medford 6
Des Moines 5
Falls Church 5
Singapore 5
Tianjin 5
Boardman 4
Dearborn 4
Dong Ket 4
Jacksonville 4
Wilmington 4
Cambridge 3
Ningbo 3
Bremen 2
Chengdu 2
Dalmine 2
Guangzhou 2
Jinan 2
Lanzhou 2
Los Angeles 2
Palermo 2
Redwood City 2
Rome 2
Shenyang 2
Taizhou 2
Venaria Reale 2
Woodbridge 2
Alexandria 1
Bari 1
Busto Arsizio 1
Catania 1
College Station 1
Haikou 1
Hefei 1
Houston 1
Lviv 1
Mykolayiv 1
Nanjing 1
Poltava 1
Poona 1
Pune 1
San Mateo 1
Scarsdale 1
Seattle 1
Verona 1
Washington 1
Totale 376
Nome #
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 102
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 72
Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy 53
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 43
null 40
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy 39
null 37
Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction. 25
null 24
Pharmacokinetics of new oral anticoagulants: implications for use in routine care 23
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence. 21
null 17
Totale 496
Categoria #
all - tutte 2.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 0 0 1 0 0 6 0 2 1 8 5 31
2020/2021100 2 8 14 14 13 6 9 4 5 21 0 4
2021/202267 1 3 1 2 3 2 5 3 1 21 5 20
2022/2023181 10 19 7 14 13 21 5 5 82 0 3 2
2023/202453 4 5 2 7 1 24 0 2 1 3 0 4
2024/20259 3 4 2 0 0 0 0 0 0 0 0 0
Totale 496